Thymosin Alpha‑1 (Tα1) 5mg Research Peptide (RUO)

Description

Overview
Thymosin Alpha‑1 (Tα1) is a synthetic 28‑amino acid peptide supplied in lyophilised
form for laboratory research use only. Preclinical literature discusses its association
with toll‑like receptor signalling pathways and immune‑related marker readouts in
defined in vitro and in vivo model systems.

Research Context
– Investigated in models examining innate immune signalling cascades and
pattern‑recognition receptor interactions.
– Studied in assay configurations referencing T‑cell marker expression and
cytokine‑pathway readouts under controlled conditions.
– Findings are model‑specific and limited to defined experimental settings.

Format and Documentation
– Lyophilised peptide; nominal content: 5 mg per vial
– Certificate of Analysis (COA) provided for each lot
– Storage guidance for research environments on label/COA

Compliance
For laboratory research use only (RUO). Not for human or veterinary use, diagnostic
or therapeutic applications.

FAQ
What is Thymosin Alpha‑1 in research contexts?
A synthetic peptide examined in controlled models involving immune‑related signalling
markers and receptor pathway readouts.

Do you provide a COA?
Yes — each lot is supplied with a Certificate of Analysis.

How should it be stored in a lab?
Follow the label/COA storage guidance suitable for research environments.

Form: Lyophilised powder
Intended use: Laboratory research use only
Documentation: Certificate of Analysis where applicable
Dispatch: Fast UK fulfilment
Storage:
– Powder: -20°C 3 years ; 4°C 2 years ; 15°C 3 month
– In solvent: -80°C 6 months ; -2°C 1 month ; 10°C 1 week

Product disclaimer
This product is supplied strictly for laboratory research use only. Not for human or veterinary